A. Fournet et al., Efficacy of the bisbenzylisoquinoline alkaloids in acute and chronic Trypanosoma cruzi murine model, INT J ANT A, 13(3), 2000, pp. 189-195
We have shown previously that daphnoline and cepharanthine are active again
st Trypanosoma cruzi and inhibited trypanothione reductase. The effects of
oral treatments with daphnoline, cepharanthine and benznidazole were examin
ed in Balb/c mice infected with T. cruzi acutely and chronically. In acute
infections, parasitaemia was significantly reduced in the daphnoline-treate
d mice compared with controls and benznidazole-treated mice. The parasitolo
gical cure rate was increased in mice treated with daphnoline. Fifty days a
fter infection, the negative serological response in both models was signif
icantly different for the three tested drugs. Daphnoline showed the highest
negative serological rate (48%). In chronically infected mice treated with
daphnoline, we were unable to detect parasites in 70% of mice. The results
obtained of oral treatment of daphnoline suggest that this bisbenzylisoqui
noline may be useful in the treatment of acute and chronic Chagas' disease.
This was not seen with cepharanthine, an excellent trypanothione reductase
inhibitor. (C) 2000 Elsevier Science B.V. and International Society of Che
motherapy. All rights reserved.